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Background
To gain insight into microRNAs (miRNAs) involved in the
regulation of the human innate immune response, we
have screened for differentially expressed miRNAs in cir-
culating leukocytes in an in vivo model of acute inflamma-
tion triggered by E. coli lipopolysaccharide (LPS) infusion.
Material and methods
Leukocyte RNA was isolated from venous blood samples
obtained from healthy male volunteers before and 4
hours after LPS-infusion. After fluorescence labeling, RNA
samples were hybridized to microarrays containing cap-
ture probes for measuring the abundance of more than
600 human miRNAs. Target genes were predicted for dif-
ferentially expressed miRNAs and then compared to
changes in genome-wide expression levels, which had
been established in a previous study.
Results
Data analysis revealed that five miRNAs consistently
responded to LPS-infusion, four of which were down-reg-
ulated (miR-146 b, miR-150, miR-342, and let-7 g) and
one was up-regulated (miR-143). By correlating to meas-
ured LPS-induced changes of the leukocyte transcriptome,
we next searched for predicted target genes, whose stabil-
ity might be under (co-)control by these miRNAs. We
found that the rapid transcriptional activation during
acute inflammation of select genes, such as the gene
encoding interleukin-1 receptor-associated kinase 2
(IRAK2) might be facilitated by decreased levels of LPS-
responsive miRNAs. The increased level of miR-143 might
be associated with the pronounced down-regulation of
the B-cell CLL/lymphoma 2 (BCL2) gene expression dur-
ing LPS endotoxemia, and could further be involved in
the translational silencing of several other predicted
inflammation-related target genes.
Conclusion
This is the first in vivo study to demonstrate relative abun-
dance of miRNA levels in peripheral blood leukocytes
during acute LPS-induced inflammation. The miRNAs
and their potential target genes identified herein contrib-
ute to the understanding of the complex transcriptional
program of innate immunity initiated by pathogens.
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